AVITA Medical (FRA:51KB) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


FRA:51KB AVITA Medical Inc FRA:51KB
60 GF Score
Price €0.61
GF Value €1.65
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

AVITA Medical's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


FRA:51KB vs NNOX, MXCT, SNWV: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, AVITA Medical's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Margin of Safety % (DCF Earnings Based) falls into.


FRA:51KB
60GF Score
AVITA Medical Inc FRA:51KB
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AVITA Medical (FRA:51KB) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of €0.61 is trading 63.3% below its estimated GF Value™ of €1.65. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for FRA:51KB:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €1.65 vs. price of €0.61 (63.3% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the FRA:51KB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
60GF Score

Get the complete analysis for FRA:51KB

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.61
Price
€1.65
GF Value